↓ Skip to main content

Melanoma-Secreted Amyloid Beta Suppresses Neuroinflammation and Promotes Brain Metastasis

Overview of attention for article published in Cancer Discovery, March 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#16 of 3,475)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
46 news outlets
blogs
1 blog
twitter
90 tweeters
facebook
1 Facebook page
reddit
1 Redditor

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Melanoma-Secreted Amyloid Beta Suppresses Neuroinflammation and Promotes Brain Metastasis
Published in
Cancer Discovery, March 2022
DOI 10.1158/2159-8290.cd-21-1006
Pubmed ID
Authors

Kevin Kleffman, Grace Levinson, Indigo V.L. Rose, Lili M. Blumenberg, Sorin A.A. Shadaloey, Avantika Dhabaria, Eitan Wong, Francisco Galán-Echevarría, Alcida Karz, Diana Argibay, Richard Von Itter, Alfredo Floristán, Gillian Baptiste, Nicole M. Eskow, James A. Tranos, Jenny Chen, Eleazar C. Vega y Saenz de Miera, Melissa Call, Robert Rogers, George Jour, Youssef Zaim Wadghiri, Iman Osman, Yue-Ming Li, Paul Mathews, Ronald B. DeMattos, Beatrix Ueberheide, Kelly V. Ruggles, Shane A. Liddelow, Robert J. Schneider, Eva Hernando

Twitter Demographics

The data shown below were collected from the profiles of 90 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 18%
Researcher 4 14%
Student > Postgraduate 3 11%
Student > Bachelor 2 7%
Other 2 7%
Other 2 7%
Unknown 10 36%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 21%
Neuroscience 3 11%
Medicine and Dentistry 2 7%
Immunology and Microbiology 2 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Other 4 14%
Unknown 10 36%

Attention Score in Context

This research output has an Altmetric Attention Score of 397. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 July 2022.
All research outputs
#56,315
of 21,691,316 outputs
Outputs from Cancer Discovery
#16
of 3,475 outputs
Outputs of similar age
#1,781
of 338,338 outputs
Outputs of similar age from Cancer Discovery
#2
of 115 outputs
Altmetric has tracked 21,691,316 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,475 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 338,338 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 115 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.